Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ketamine on the Reward Circuitry of Suicidal Patients: An MRI Study

NCT02532153 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02532153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02532153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ketamine on the Reward Circuitry of Suicidal Patients: An MRI Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Withdrawn
Start date
February 28, 2017
Completion date
February 28, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation, suicide